Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

CARE Ratings Ltd announces Q3 FY19, 9M FY19 results

Posted On: 2019-02-12 12:32:52

The Board of Directors of CARE Ratings approved the quarter ended December 2018 and nine months ended December 2018 results in the Board Meeting held on Monday the 11th of February 2019.

Consolidated Financial Results

CARE Ratings consolidated income from operations for the nine months ended Dec 31 2018 is Rs. 229.55 crores as against Rs. 233.76 crores in the corresponding nine months of previous financial year. Consolidated total income for the nine months ended Dec 31 2018 is Rs 250.33 crores as against Rs. 251.41 crores in the corresponding nine months of previous financial year. Profit after tax moderated to Rs. 101.38 crores as against Rs. 120.35 crores in the corresponding nine months of previous financial year.

Standalone Financial Results

CARE Ratings standalone income from operations for the nine months ended Dec 31 2018 is Rs. 215.87 crores as against Rs. 227.17 crores in the corresponding nine month of previous financial year. Standalone total income for the nine months ended Dec 31 2018 is Rs 236.23 crores as against Rs. 244.57 crores in the corresponding nine months of previous financial year. Profit after tax moderated to Rs. 100.35 crores as against Rs. 121.12 crores in the corresponding nine months of previous financial year.

The Board of Directors has declared third interim dividend of Rs. 6/- per share (of Rs. 10/- face value) for the quarter ended December 31, 2018.

Major factors affecting results of Nine months ended December 2018

The Company had changed the estimates for revenue recognition prospectively from FY18. Accordingly, some income booked in previous year is not available in the current year. The revenue for nine months ended December 2017 was higher by Rs. 18.11 crore and PAT was higher by Rs. 13.14 crore in nine months ended December 2017 on account of the above.

Nine months ended December 2018 includes ESOP charge of Rs. 9.85 crore (Rs.5.00 crore in nine months ended December 2017) resulting in higher expense.

NBFCs facing liquidity challenges.

Operational Data

The total debt rated by your company was Rs.11.46 Lakh Crores in nine months ended December 2018 as against Rs.10.40 Lakh Crores in corresponding nine months of previous financial year. This included Rs 4.10 Lakh Crores in bonds, Rs 4.88 Lakh Crores bank loans and Rs 2.48 Lakh Crores in short term ratings (including CPs) for nine months ended December 2018.

Economic backdrop

The first nine months of the year were quite challenging especially in Q3 when the system confronted a liquidity issue on the NBFC front. With support coming from the RBI through liquidity measures to augment flow of funds to this sector, stability was achieved gradually. However, the overall flow of funds in the economy was affected in a disparate manner.

Total corporate debt raised in the market was lower during the first 9 months at Rs 4 lakh crore as against Rs 4.6 lkh crore last year. Overall growth in bank credit during this period over March was 7.7% as against 2.9% last year. However, growth in credit to industry was 1.9% (-1.7%) while that to services was 8.9% (0.5%). Outstanding CPs increased by 35.1% during this period.

The RBI had also increased interest rates during the year and maintained a stance of calibrated tightening of the repo rate in the December policy. The performance of your company needs to be viewed against this background.

Commenting on the results Rajesh Mokashi, MD & CEO, said, 'The third quarter has been particularly challenging for the financial sector with the liquidity challenges affecting overall borrowing activity. On the positive side we do see the situation normalizing following the effective measures taken by the central bank. While Q4 macro-economic conditions should be better, we would take a conservative view on incremental growth in credit as well as debt issuances with the market still taking a wait and watch stance till the run up to the Elections.'

Shares of CARE Ratings Ltd was last trading in BSE at Rs.970 as compared to the previous close of Rs. 982.7. The total number of shares traded during the day was 828 in over 104 trades.

The stock hit an intraday high of Rs. 984.55 and intraday low of 968.4. The net turnover during the day was Rs. 804947.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Confluence 2019 by Mahindra World City delves into 'Thinking Cities: The Rise of Resilience'

Uflex Honoured with 'Excellence in Packaging -Beverages' at The ET Polymers Awards 2019

Vikram Thermo India Ltd posts net profit of Rs. 0.60 crore in Q3

Lumax Auto Technologies Ltd updates on the PCB business

Robert Bosch Automotive Steering GmbH terminates JV agreement with ZF Steeting Gear India Ltd

Karnataka Bank bags ET Now - BFSI Awards

V-Mart Retail Ltd opens new store in Bihar, closes one

KPI Global bags order of 213.75KW Solar Power Plant under Captive Power Producer

Karnataka Bank shifts its Arehalli Branch to new premises on 16-02-2019

Shalby Hospitals Bestowed With Best IT Enabled Hospital Award 2019

PNC Infratech bags Rs.186 crore PWD road project in UP

Karnataka Bank opens its 838th Branch at Mysuru-Ramanuja Road on 16-02-2019

Ujaas Energy to launch E Scooter

Ground breaking Ceremony of Hooghly Cochin Shipyard Limited's New Yard Construction at Nazirgunge, Kolkata

Dr. Reddy's Laboratories Ltd receives EIR for Formulations Unit at Duvvada, Vizag

Karnataka Bank introduces 475 days special term deosit Scheme

Tech Mahindra Ltd board to consider buy back on Feb 21, 2019

Megasoft announces third quarter results for FY19

HCL Technologies and IBM Collaborate to Accelerate Clients' Hybrid Cloud Journey

Simplex Infra announces Q3FY19 results

Seya Industries Ltd 9MFY19: Sustained Momentum in Business

Alembic Pharmaceuticals announces USFDA Approval for Moxifloxacin Ophthalmic Solution USP 1 0.5%.

Gujarat Terce Laboratories Ltd launces Acolate Plus Tablet

BEML at Aero Show

HOCL approves proposal for sale of 8.08 acres land at Panvel

NIIT recognised as 'Best Training Institution' at the 9th Indian Education Congress at Awards 2019

Sonata Software completes acquisition of Sopris Systems LLC

Karda Constructions Limited announces 3QFY2019 results

Diligent Media Corporation Limited concludes sale of leasehold land for Rs. 57.32 crores

PNC launches streaming of movies on Netflix

Lupin launches Clobazam Oral Suspension, 2.5mg/ml

Technocraft Industries India Ltd opens operations in New Zealand

TRF Ltd approves issue of NCRPS to Tata Steel Ltd

Raminfo Q3 FY19 net profit increases 14.3% with revenue being Rs. 7.60 Crs

Paramount Communications Ltd bags order of Rs. 69.53 crores

ICRA assigns ratings to Nahar Industrial Enterprises Ltd

Sun Pharma returns product rights of Elepsia™ XR back to SPARC

NBCC India Ltd submits resolution plan for Jaypee Infratech Ltd

Lumax Industries Ltd announces setting up of in-house Electronic Facilities

IDFC FIRST Bank to sell stake in Digikredit

Karnataka Bank MD & CEO Shri Mahabaleshwara M S, conferred with 'CEO with HR Orientation Award'

Aanchal Ispat Ltd reports jump in Q3 PAT to Rs. 2.21 crores

Celestial Biolabs Ltd Q3 net profit slides to Rs. 0.07 crore

Donear Industries Ltd reports Q3 FY19 net profit of Rs. 5.14 crores

Mindteck Reports Financial Results for the Third Quarter Ending December 31, 2018

India Home Loan Ltd board approves fund raising proposal through warrants

Mangalore Chemicals & Fertilizers Ltd updates on annual maintenance

Zensar on the path of Rapid Innovation

ONGC board declares interim dividend of Rs. 5.25

Stovec Industries Ltd board recommends final dividend of Rs. 55







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019